Cargando…
Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
Mutant Cu/Zn superoxide dismutase (SOD1) causes mitochondrial alterations that contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When mitochondria are damaged, cells activate mitochondria quality control (MQC) mechanisms leading to mitophagy. Here, we show that in the spinal...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180298/ https://www.ncbi.nlm.nih.gov/pubmed/30126943 http://dx.doi.org/10.15252/emmm.201808888 |
_version_ | 1783362173287792640 |
---|---|
author | Palomo, Gloria M Granatiero, Veronica Kawamata, Hibiki Konrad, Csaba Kim, Michelle Arreguin, Andrea J Zhao, Dazhi Milner, Teresa A Manfredi, Giovanni |
author_facet | Palomo, Gloria M Granatiero, Veronica Kawamata, Hibiki Konrad, Csaba Kim, Michelle Arreguin, Andrea J Zhao, Dazhi Milner, Teresa A Manfredi, Giovanni |
author_sort | Palomo, Gloria M |
collection | PubMed |
description | Mutant Cu/Zn superoxide dismutase (SOD1) causes mitochondrial alterations that contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When mitochondria are damaged, cells activate mitochondria quality control (MQC) mechanisms leading to mitophagy. Here, we show that in the spinal cord of G93A mutant SOD1 transgenic mice (SOD1‐G93A mice), the autophagy receptor p62 is recruited to mitochondria and mitophagy is activated. Furthermore, the mitochondrial ubiquitin ligase Parkin and mitochondrial dynamics proteins, such as Miro1, and Mfn2, which are ubiquitinated by Parkin, and the mitochondrial biogenesis regulator PGC1α are depleted. Unexpectedly, Parkin genetic ablation delays disease progression and prolongs survival in SOD1‐G93A mice, as it slows down motor neuron loss and muscle denervation and attenuates the depletion of mitochondrial dynamics proteins and PGC1α. Our results indicate that Parkin is a disease modifier in ALS, because chronic Parkin‐mediated MQC activation depletes mitochondrial dynamics‐related proteins, inhibits mitochondrial biogenesis, and worsens mitochondrial dysfunction. |
format | Online Article Text |
id | pubmed-6180298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61802982018-10-18 Parkin is a disease modifier in the mutant SOD1 mouse model of ALS Palomo, Gloria M Granatiero, Veronica Kawamata, Hibiki Konrad, Csaba Kim, Michelle Arreguin, Andrea J Zhao, Dazhi Milner, Teresa A Manfredi, Giovanni EMBO Mol Med Research Articles Mutant Cu/Zn superoxide dismutase (SOD1) causes mitochondrial alterations that contribute to motor neuron demise in amyotrophic lateral sclerosis (ALS). When mitochondria are damaged, cells activate mitochondria quality control (MQC) mechanisms leading to mitophagy. Here, we show that in the spinal cord of G93A mutant SOD1 transgenic mice (SOD1‐G93A mice), the autophagy receptor p62 is recruited to mitochondria and mitophagy is activated. Furthermore, the mitochondrial ubiquitin ligase Parkin and mitochondrial dynamics proteins, such as Miro1, and Mfn2, which are ubiquitinated by Parkin, and the mitochondrial biogenesis regulator PGC1α are depleted. Unexpectedly, Parkin genetic ablation delays disease progression and prolongs survival in SOD1‐G93A mice, as it slows down motor neuron loss and muscle denervation and attenuates the depletion of mitochondrial dynamics proteins and PGC1α. Our results indicate that Parkin is a disease modifier in ALS, because chronic Parkin‐mediated MQC activation depletes mitochondrial dynamics‐related proteins, inhibits mitochondrial biogenesis, and worsens mitochondrial dysfunction. John Wiley and Sons Inc. 2018-08-20 2018-10 /pmc/articles/PMC6180298/ /pubmed/30126943 http://dx.doi.org/10.15252/emmm.201808888 Text en © 2018 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Palomo, Gloria M Granatiero, Veronica Kawamata, Hibiki Konrad, Csaba Kim, Michelle Arreguin, Andrea J Zhao, Dazhi Milner, Teresa A Manfredi, Giovanni Parkin is a disease modifier in the mutant SOD1 mouse model of ALS |
title | Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
|
title_full | Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
|
title_fullStr | Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
|
title_full_unstemmed | Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
|
title_short | Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
|
title_sort | parkin is a disease modifier in the mutant sod1 mouse model of als |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180298/ https://www.ncbi.nlm.nih.gov/pubmed/30126943 http://dx.doi.org/10.15252/emmm.201808888 |
work_keys_str_mv | AT palomogloriam parkinisadiseasemodifierinthemutantsod1mousemodelofals AT granatieroveronica parkinisadiseasemodifierinthemutantsod1mousemodelofals AT kawamatahibiki parkinisadiseasemodifierinthemutantsod1mousemodelofals AT konradcsaba parkinisadiseasemodifierinthemutantsod1mousemodelofals AT kimmichelle parkinisadiseasemodifierinthemutantsod1mousemodelofals AT arreguinandreaj parkinisadiseasemodifierinthemutantsod1mousemodelofals AT zhaodazhi parkinisadiseasemodifierinthemutantsod1mousemodelofals AT milnerteresaa parkinisadiseasemodifierinthemutantsod1mousemodelofals AT manfredigiovanni parkinisadiseasemodifierinthemutantsod1mousemodelofals |